Valby, Denmark

Lene Lange

USPTO Granted Patents = 28 

 

Average Co-Inventor Count = 4.2

ph-index = 5

Forward Citations = 146(Granted Patents)


Location History:

  • Bagsvaerd, DK (1999)
  • Valby, DK (1997 - 2020)

Company Filing History:


Years Active: 1997-2020

Loading Chart...
Loading Chart...
28 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Lene Lange in Biotechnology

Introduction

Lene Lange, based in Valby, Denmark, is a prolific inventor with an impressive portfolio of 28 patents. Her groundbreaking work in biotechnology, particularly in the field of glycoside hydrolases from thermophilic fungi, has made significant contributions to various industrial applications.

Latest Patents

Lange's recent patents focus on isolated polypeptides that exhibit cellulolytic and hemicellulitic activities. These inventions include polynucleotides encoding these polypeptides, as well as nucleic acid constructs, vectors, and host cells that incorporate these new polynucleotides. The innovative methods of producing and utilizing these polypeptides highlight her expertise in enhancing the efficiency of biomass conversion processes.

Career Highlights

Throughout her career, Lene Lange has been associated with prominent companies such as Novozymes A/S and Novo Nordisk A/S. Her experience in these leading biotechnology firms has allowed her to advance her research and innovations in significant ways.

Collaborations

Lange has collaborated with several esteemed professionals in the field, including Wenping Wu and Kirk Matthew Schnorr. These collaborations have enriched her research and contributed to the successful development of her patented technologies.

Conclusion

Lene Lange's innovative contributions in the biotechnology sector exemplify the impact of dedicated inventors on the advancement of science and technology. Her work continues to pave the way for effective solutions in the field, showcasing the importance of collaboration and research in pushing the boundaries of current scientific understanding.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…